wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35050501-798FDACA-DFDA-4DCD-8CBE-CB26142E64AC
Q35050501-798FDACA-DFDA-4DCD-8CBE-CB26142E64AC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35050501-798FDACA-DFDA-4DCD-8CBE-CB26142E64AC
Phase 2 trial of rituximab and bortezomib in patients with relapsed or refractory mantle cell and follicular lymphoma
P2860
Q35050501-798FDACA-DFDA-4DCD-8CBE-CB26142E64AC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35050501-798FDACA-DFDA-4DCD-8CBE-CB26142E64AC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f5a0735926040b02fb7cd52300141f2e96eb8e38
P2860
Combination bortezomib and rituximab treatment affects multiple survival and death pathways to promote apoptosis in mantle cell lymphoma.